Literature DB >> 8799201

Dissociation of demyelination and viral clearance in congenitally immunodeficient mice infected with murine coronavirus JHM.

J J Houtman1, J O Fleming.   

Abstract

Infection of rodents with murine coronavirus JHM results in a subacute or chronic demyelinating disease which serves as a model for the human disease multiple sclerosis. Previous studies with JHMV have established a role for the immune system in both viral clearance and demyelination. To further clarify the role of the immune system in JHMV pathogenesis, several strains of congenitally immunodeficient mice were studied. Infection of immunocompetent C57BL/6 mice with JHMV resulted in severe paralysis and demyelination and complete clearance of infectious virus from the brain (C+D+ phenotype). In contrast, infected SCID mice showed little or no paralysis or demyelination and were unable to clear infectious virus (C-D- phenotype). Athymic nude mice and a proportion of mice lacking MHC Class I or II expression exhibited robust demyelination but did not completely clear infectious virus from the brain (C-D+ phenotype). These results are consistent with an immune-mediated mechanism for JHMV-induced demyelination, but indicate that the immune mechanisms which participate in demyelination and viral clearance are distinct. It may thus be possible to experimentally alter immunopathological responses without impairing antimicrobial immunity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8799201     DOI: 10.3109/13550289609146543

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  64 in total

1.  Cytotoxic T-cell-resistant variants arise at early times after infection in C57BL/6 but not in SCID mice infected with a neurotropic coronavirus.

Authors:  L Pewe; S Xue; S Perlman
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  Mouse hepatitis virus is cleared from the central nervous systems of mice lacking perforin-mediated cytolysis.

Authors:  M T Lin; S A Stohlman; D R Hinton
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

Review 3.  Murine coronavirus infection: a paradigm for virus-induced demyelinating disease.

Authors:  T E Lane; M J Buchmeier
Journal:  Trends Microbiol       Date:  1997-01       Impact factor: 17.079

4.  Expression of cellular oncogene Bcl-xL prevents coronavirus-induced cell death and converts acute infection to persistent infection in progenitor rat oligodendrocytes.

Authors:  Yin Liu; Xuming Zhang
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

5.  A central role for CD4(+) T cells and RANTES in virus-induced central nervous system inflammation and demyelination.

Authors:  T E Lane; M T Liu; B P Chen; V C Asensio; R M Samawi; A D Paoletti; I L Campbell; S L Kunkel; H S Fox; M J Buchmeier
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

6.  Important roles for gamma interferon and NKG2D in gammadelta T-cell-induced demyelination in T-cell receptor beta-deficient mice infected with a coronavirus.

Authors:  Ajai A Dandekar; Katherine O'Malley; Stanley Perlman
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

7.  Virus-specific antibody, in the absence of T cells, mediates demyelination in mice infected with a neurotropic coronavirus.

Authors:  Taeg S Kim; Stanley Perlman
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

8.  A severe acute respiratory syndrome-associated coronavirus-specific protein enhances virulence of an attenuated murine coronavirus.

Authors:  Lecia Pewe; Haixia Zhou; Jason Netland; Chandra Tangudu; Heidi Olivares; Lei Shi; Dwight Look; Thomas Gallagher; Stanley Perlman
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  A mechanism of virus-induced demyelination.

Authors:  Jayasri Das Sarma
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-06-21

10.  Microglia are required for protection against lethal coronavirus encephalitis in mice.

Authors:  D Lori Wheeler; Alan Sariol; David K Meyerholz; Stanley Perlman
Journal:  J Clin Invest       Date:  2018-01-29       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.